# Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

> **NCT00005884** · PHASE3 · COMPLETED · sponsor: **University of Wisconsin, Madison**

## Conditions studied

- Non-melanomatous Skin Cancer

## Interventions

- **DRUG:** eflornithine

## Key facts

- **NCT ID:** NCT00005884
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2000-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005884, "Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00005884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*